Zobrazeno 1 - 10 of 24 pro vyhledávání: '"C H J, Swan"'
1
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study
Autor: E. T. Swarbrick, G. D. Kerr, J. A. Gibson, J. R. B. Green, P. C. Thornton, C. H. J. Swan
Publikováno v: Alimentary Pharmacology & Therapeutics. 19:435-442
Summary Background : The patient-centred approach is new to the management of ulcerative colitis. To date, it has only been shown to be successful in a short-term study. Aim : To assess the feasibility, safety and efficacy of patient-led dosing using
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4eb0c7b3907659f69fe59845e241f7a4
https://doi.org/10.1111/j.1365-2036.2004.01866.x
Zobrazit plný text záznamu
3
Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy
Autor: D. Campbell, N. A. Dent, C. H. J. Swan, R. F. A. Logan, R. F. Mccloy, M. W. L. Gear, G. D. Bell, J. E. Charlton
Publikováno v: Gut. 32:823-827
(1) Safety and monitoring should be part of a quality assurance programme for endoscopy units. (2) Resuscitation equipment and drugs must be available in the endoscopy and recovery areas. (3) Staff of all grades and disciplines should be familiar wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6c314b3ab37de6b6e9bc934bde86d033
https://doi.org/10.1136/gut.32.7.823
Zobrazit plný text záznamu
4
Gastric Ulcer Healing
Autor: K. D. Bardhan, R. Walker, C. Hinchliffe, K. Bose, Pamela Morris, Mary Thompson, J. P. Miller, E. Toivanen, R. P. H. Thompson, P. Patrier, P. Pikkarainen, O. Keyrilainen, R. Yli-Uotila, C. H. J. Swan, C. Klepping, S. Tarpila, Moira H. Thomson, S. Harris, Helen C. Massey, D. Ipe
Publikováno v: Journal of Clinical Gastroenterology. 13:157-162
Enprostil is a synthetic prostaglandin E2 analogue with gastric antisecretory and mucosal protective properties. We compared the effects of enprostil and ranitidine on the healing of gastric ulcers and the subsequent relapse rates over 6 months. Pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e1436d2b0f11de4200af40f8f2296f8
https://doi.org/10.1097/00004836-199104000-00008
Zobrazit plný text záznamu
5
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study
Autor: J R B, Green, C H J, Swan, J A, Gibson, G D, Kerr, E T, Swarbrick, P C, Thornton
Publikováno v: Alimentary pharmacologytherapeutics. 19(4)
The patient-centred approach is new to the management of ulcerative colitis. To date, it has only been shown to be successful in a short-term study.To assess the feasibility, safety and efficacy of patient-led dosing using balsalazide in the long-ter
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e34f47f6ddb5fe36b4bda80b3665fee
https://pubmed.ncbi.nlm.nih.gov/14871283
Zobrazit plný text záznamu
6
Persistent monoarthritis and occult coeliac disease
Autor: P. T. Dawes, T. E. Hothersall, C. H. J. Swan, A. A. Borg
Publikováno v: Postgraduate Medical Journal. 70:51-53
Summary Arthritis is a recognized complication of untreated coeliac disease. Symptoms and signs usually respond to the institution of a gluten-free diet. We report a case of occult coeliac disease presenting as a monoarthritis. Severe and progressive
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda79f6e98bf4d47c01e2e1731358fd9
https://doi.org/10.1136/pgmj.70.819.51
Zobrazit plný text záznamu
7
Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months
Autor: E. T. Swarbrick, J. A. Gibson, P. Brown, G. D. Kerr, C. H. J. Swan, A. Rowlinson, J. R. B. Green, P. C. Thornton
Publikováno v: Alimentary pharmacologytherapeutics. 6(5)
In a four-centre prospective double-blind trial, 108 patients with ulcerative colitis in remission were randomized to receive balsalazide in doses of 3 g or 6 g/day for 12 months. The patients were assessed at 3-monthly intervals clinically, sigmoido
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a29c54d4defd2999fa27e319e238716
https://pubmed.ncbi.nlm.nih.gov/1420754
Zobrazit plný text záznamu
8
Mucosal peptide hydrolase and brush-border marker enzyme activities in three regions of the small intestine of rats with experimental uraemia
Autor: J. R. B. Green, D. J. Haines, J. F. Woodley, C. H. J. Swan
Publikováno v: Clinical science (London, England : 1979). 79(6)
1. The activities of nine peptide hydrolases and three non-peptidase brush-border marker enzymes have been quantified in crude homogenates prepared from the proximal, mid and distal regions of small-intestinal mucosa for sham-operated (n = 9) and ura
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd09784c0cee8d447411b497a9261123
https://pubmed.ncbi.nlm.nih.gov/2176955
Zobrazit plný text záznamu
10
Experimental Uraemia with Associated Plasma Amino Acid Abnormalities but without Retarded Food Intake and Weight Gain
Autor: J. R. B. Green, C. H. J. Swan, D. J. Haines, J. F. Woodley
Publikováno v: Nephron. 53:233-237
A rat model of moderate uraemia is described in which uraemic animals attain normal food intake and weight gain. Despite the low levels of the induced uraemia, which has been well defined, changes in plasma amino acid concentrations associated with e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076d801ec5da491bd5b8e5feec42304a
https://doi.org/10.1159/000185750
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje